Radcliffe Capital Management’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Radcliffe Capital Management’s Portfolio CLDI.WS Stock Details CLDI.WS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$31.6K	Hold
2023 Q1	$13K	Hold
2022 Q4	$2.69M	Hold
2022 Q3	$2.61M	Buy
2022 Q2	$1.99M	Hold
2022 Q1	$1.98M	Hold
2021 Q4	$1.96M	Buy